We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Appeal Seeks Release of PTC Therapeutics’ Clinical Report on Duchenne Drug Translarna
EMA Appeal Seeks Release of PTC Therapeutics’ Clinical Report on Duchenne Drug Translarna
The EMA is appealing a temporary injunction from the General Court of the European Union that prevents the agency from releasing a clinical study report on PTC Therapeutics’ Duchenne muscular dystrophy drug Translarna.